IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $26,000 | -72.3% | 589 | -64.5% | 0.00% | – |
Q4 2020 | $94,000 | +118.6% | 1,658 | +75.1% | 0.00% | – |
Q3 2020 | $43,000 | -42.7% | 947 | -25.6% | 0.00% | – |
Q2 2020 | $75,000 | +5.6% | 1,272 | -8.6% | 0.00% | – |
Q1 2020 | $71,000 | -93.6% | 1,392 | -92.5% | 0.00% | -100.0% |
Q3 2019 | $1,101,000 | +18.4% | 18,647 | +62.7% | 0.00% | 0.0% |
Q1 2019 | $930,000 | +43.5% | 11,460 | -4.4% | 0.00% | +100.0% |
Q4 2018 | $648,000 | -10.7% | 11,984 | -14.9% | 0.00% | 0.0% |
Q3 2018 | $726,000 | +172.9% | 14,080 | +179.0% | 0.00% | – |
Q3 2017 | $266,000 | -33.7% | 5,047 | -34.9% | 0.00% | -100.0% |
Q2 2017 | $401,000 | – | 7,749 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |